Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 15.1660.74-30.36-23.03-

What is the latest Core EBITDA Growth ratio of PIRAMAL PHARMA ?

The latest Core EBITDA Growth ratio of PIRAMAL PHARMA is 15.16 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202515.16
Mar202460.74
Mar2023-30.36
Mar2022-23.03
Mar2021-

How is Core EBITDA Growth of PIRAMAL PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 15.16
-75.04
Mar2024 60.74
Positive
Mar2023 -30.36
Negative
Mar2022 -23.03
0
Mar2021 0 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Core EBITDA Growth ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹19,127.2 Cr 0.8% -6.2% -37.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹411,150.0 Cr -0.9% -3.9% 1.3% Stock Analytics
DIVIS LABORATORIES ₹156,129.0 Cr -0.4% -7.6% 5.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,312.0 Cr -2% -7.5% 27.3% Stock Analytics
DR REDDYS LABORATORIES ₹99,445.2 Cr -1.5% -9.3% 3.8% Stock Analytics
CIPLA ₹98,210.2 Cr 1.7% -8.3% -16.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.8%

-6.2%

-37.5%

SENSEX

7.8%

-2%

0.2%


You may also like the below Video Courses